Pharmaceuticals – Bizlytik Intelligence & Technologies https://bizlytik.com Tue, 07 Mar 2023 11:39:42 +0000 en-US hourly 1 https://wordpress.org/?v=5.3.17 https://bizlytik.com/wp-content/uploads/2020/01/cropped-New-Project-32x32.png Pharmaceuticals – Bizlytik Intelligence & Technologies https://bizlytik.com 32 32 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market By Type (Stimulants (Methylphenidate, Dextroamphetamine, Amphetamine, and Others) and Non-Stimulants (Atomoxetine, Guanfacine, Bupropion, and Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Speciality Clinics, and e-Commerce), Industry Trends, Estimation & Forecast, 2023-2030 https://bizlytik.com/report/attention-deficit-hyperactivity-disorder-adhd-drugs-market/?utm_source=rss&utm_medium=rss&utm_campaign=attention-deficit-hyperactivity-disorder-adhd-drugs-market https://bizlytik.com/report/attention-deficit-hyperactivity-disorder-adhd-drugs-market/#respond Wed, 07 Sep 2022 09:44:11 +0000 https://bizlytik.com/?post_type=product&p=40193 The Attention Deficit Hyperactivity Disorder (ADHD) Drugs market is projected to reach 19.1 billion US$ by 2030, at a CAGR of 4.5% during the forecast period.

The post Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market By Type (Stimulants (Methylphenidate, Dextroamphetamine, Amphetamine, and Others) and Non-Stimulants (Atomoxetine, Guanfacine, Bupropion, and Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Speciality Clinics, and e-Commerce), Industry Trends, Estimation & Forecast, 2023-2030 appeared first on Bizlytik Intelligence & Technologies.

]]> The Attention Deficit Hyperactivity Disorder (ADHD) Drugs market is projected to reach 19.1 billion US$ by 2030, at a CAGR of 4.5% during the forecast period.

The post Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market By Type (Stimulants (Methylphenidate, Dextroamphetamine, Amphetamine, and Others) and Non-Stimulants (Atomoxetine, Guanfacine, Bupropion, and Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Speciality Clinics, and e-Commerce), Industry Trends, Estimation & Forecast, 2023-2030 appeared first on Bizlytik Intelligence & Technologies.

]]> https://bizlytik.com/report/attention-deficit-hyperactivity-disorder-adhd-drugs-market/feed/ 0 Alprazolam Market By Type (Xanax, Niravam, and Others), By Application (Anxiety, Panic Disorders, and Others), Industry Trends, Estimation & Forecast, 2023-2030 https://bizlytik.com/report/alprazolam-market/?utm_source=rss&utm_medium=rss&utm_campaign=alprazolam-market https://bizlytik.com/report/alprazolam-market/#respond Wed, 07 Sep 2022 09:15:01 +0000 https://bizlytik.com/?post_type=product&p=40185 The Alprazolam market is projected to reach 152.5 million US$ by 2030, at a CAGR of 4.8% during the forecast period.

The post Alprazolam Market By Type (Xanax, Niravam, and Others), By Application (Anxiety, Panic Disorders, and Others), Industry Trends, Estimation & Forecast, 2023-2030 appeared first on Bizlytik Intelligence & Technologies.

]]> The Alprazolam market is projected to reach 152.5 million US$ by 2030, at a CAGR of 4.8% during the forecast period.

The post Alprazolam Market By Type (Xanax, Niravam, and Others), By Application (Anxiety, Panic Disorders, and Others), Industry Trends, Estimation & Forecast, 2023-2030 appeared first on Bizlytik Intelligence & Technologies.

]]> https://bizlytik.com/report/alprazolam-market/feed/ 0